Cargando…
Phosphates in medications: Impact on dialysis patients
Maintaining phosphorus balance in in-center hemodialysis (ICHD) patients is problematic despite recommended dietary restriction, dialysis, and phosphate binder use. Rarely is P content in prescribed medications considered, but this source should raise concern. Data was obtained from the Fresenius Ki...
Autores principales: | Sawin, Dixie-Ann, Ma, Lin, Stennett, Amanda, Ofsthun, Norma, Himmele, Rainer, Kossmann, Robert J., Maddux, Franklin W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264818/ https://www.ncbi.nlm.nih.gov/pubmed/32049627 http://dx.doi.org/10.5414/CN109853 |
Ejemplares similares
-
Real-world effectiveness of sucroferric oxyhydroxide in patients on chronic hemodialysis: A retrospective analysis of pharmacy data
por: Coyne, Daniel W., et al.
Publicado: (2017) -
One-Year Historical Cohort Study of the Phosphate Binder Sucroferric Oxyhydroxide in Patients on Maintenance Hemodialysis
por: Kendrick, Jessica, et al.
Publicado: (2019) -
Emergency Response to Natural Disasters: The Experience of Fresenius Medical Care
por: Sawin, Dixie-Ann, et al.
Publicado: (2023) -
Impacts of dialysis adequacy and intradialytic hypotension on changes in dialysis recovery time
por: Guedes, Murilo, et al.
Publicado: (2020) -
Transmission of SARS-CoV-2 Considering Shared Chairs in Outpatient Dialysis: A Real-World Case-Control Study
por: Thadhani, Ravi, et al.
Publicado: (2021)